BCAA 2:1:1 Swiss Pharmaceuticals Swiss Pharmaceuticals

£57.00

BCAA 2:1:1 Swiss Pharmaceuticals provides branched-chain amino acids in the scientifically researched 2:1:1 ratio of leucine, isoleucine, and valine for laboratory protein synthesis studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
BCAA 2:1:1 Swiss Pharmaceuticals Swiss Pharmaceuticals
BCAA 2:1:1 Swiss Pharmaceuticals Swiss Pharmaceuticals
£57.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications of Swiss Pharmaceuticals BCAA 2:1:1

BCAA 2:1:1 Swiss Pharmaceuticals is a branched-chain amino acid formulation containing leucine, isoleucine, and valine in the established 2:1:1 ratio for laboratory research applications. These essential amino acids serve as fundamental building blocks in protein synthesis studies and cellular metabolism research. Researchers at Stroid UK Shop utilise this formulation to examine muscle protein synthesis pathways, nitrogen balance mechanisms, and amino acid transport systems in controlled laboratory environments.

Biochemical Properties and Molecular Mechanisms

The three branched-chain amino acids in this formulation exhibit distinct molecular characteristics that researchers investigate across various cellular models. Leucine acts as a primary activator of the mTOR pathway, making it valuable for studies examining protein synthesis regulation. Isoleucine research focuses on glucose metabolism and energy production pathways, while valine studies concentrate on muscle tissue nitrogen balance. Scientists working with branched-chain amino acid research compounds analyse these mechanisms through in-vitro cellular assays and molecular pathway investigations.

Laboratory studies demonstrate that the 2:1:1 ratio optimises the synergistic effects of these amino acids in cellular environments. Researchers examine how this specific ratio influences protein synthesis rates, cellular energy metabolism, and amino acid competition at transport sites. The Swiss Pharmaceuticals formulation provides consistent purity levels for reproducible research outcomes. Studies comparing this ratio to other BCAA combinations help researchers understand optimal amino acid proportions for various experimental protocols, supporting investigations alongside other research compounds including selective androgen receptor modulators and research peptides.

Technical Specifications

BCAA 2:1:1 Swiss Pharmaceuticals Research Specifications
Parameter Specification
Leucine Content 50% of total amino acid profile
Isoleucine Content 25% of total amino acid profile
Valine Content 25% of total amino acid profile
Purity Verify with supplier
Storage Conditions Room temperature, dry environment
Shelf Life 24 months from manufacture date
Solubility Water soluble for research preparation
Testing HPLC verified amino acid profile

Laboratory Use and Compliance

This BCAA 2:1:1 formulation is manufactured by Swiss Pharmaceuticals exclusively for in-vitro research applications. Researchers utilise this compound to investigate amino acid metabolism, protein synthesis pathways, and cellular energy production mechanisms in controlled laboratory settings. The standardised ratio enables consistent experimental conditions across multiple research protocols. All studies should be conducted in appropriate laboratory facilities by qualified research personnel following established safety protocols for amino acid research compounds.

This product is sold strictly for laboratory research purposes only. Not approved for human consumption or clinical use. Researchers must comply with all applicable regulations and institutional guidelines when conducting studies with this compound.

Related